Ayala Pharmaceuticals, Inc. — Form D

Ayala Pharmaceuticals, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-24. $1.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Richard A BermanDirectorSanta Monica, CA
Thomas A McKearnDirectorPRINCETON, NJ
John A RothmanExecutive OfficerPRINCETON, NJ
Thomas MooreDirectorFranklin, TN
Thomas MooreExecutive OfficerFranklin, TN
Richard BermanDirectorMerritt Island, FL
Mark J RosenblumExecutive OfficerHouston, TX
David SidranskyDirectorGermantown, MD
Andres A GutierrezExecutive OfficerMONMOUTH JUNCTION, NJ
Igor A GitelmanExecutive OfficerMONMOUTH JUNCTION, NJ
Pini A OrbachDirectorMONMOUTH JUNCTION, NJ
Murray A GoldbergDirectorMONMOUTH JUNCTION, NJ
Vered A Bisker-LeibDirectorMONMOUTH JUNCTION, NJ
Yuval A CabillyDirectorMONMOUTH JUNCTION, NJ
Bridget A MartellDirectorMONMOUTH JUNCTION, NJ
Roy A GolanExecutive OfficerMONMOUTH JUNCTION, NJ
Robert A SpiegelDirectorMONMOUTH JUNCTION, NJ
David A SidranskyDirectorMONMOUTH JUNCTION, NJ
Roni A AppelDirectorMONMOUTH JUNCTION, NJ
Ken A BerlinDirectorMonmouth Junction, NJ
Ken A BerlinExecutive OfficerMonmouth Junction, NJ
Kenneth BerlinDirectorMonmouth Junction, NJ
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Samir KhleifDirectorMonmouth Junction, NJ
Igor GitelmanDirectorMonmouth Junction, NJ

Other filings by this issuer (13)

FiledFormOfferingSold
2023-11-02D$434K$434K
2022-02-11D$4.8M$4.8M
2021-04-28D$11.1M$11.1M
2012-12-13D$10.0M
2012-06-06D$715K
2012-05-29D$4.5M
2011-11-15D$2.0M
2011-05-27D$6.0M
2010-11-15D$835K
2010-07-30D$7.5M$7.5M
2009-10-22D$50K
2009-10-05D$5.0M$5.0M
2009-10-01D$962K

More